What does symproic and other — cost mean?

Reflects the total direct costs associated with producing, distributing, and supporting the Symproic product line. Monitoring this metric helps assess the direct profitability and cost-efficiency of this specific business segment.

Collegium Pharmaceutical, Inc. COLL Symproic and other — Cost

Other product segments

Jornay PM

$635M0.0%

Belbuca

$360M0.0%

Symproic

$70M0.0%

Similar metrics at other companies

PBFCorporate — Cost of products and other

$0—

OIIProduct — Cost of services and products

$115.3M-3.1%

SYYSYGMA — Cost of Sales

$1.97B+2.9%

AVNSCost of Services

$88M+13.3%

NATLProduct — Cost of products and services

$188M+17.5%

OTEXProfessional service and other — Cost of revenues:

$63.51M-3.0%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+17.9%

Enterprise value$869.67M-0.3%

P/E15.4×-6.9×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Collegium Pharmaceutical, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s symproic and other — cost.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s symproic and other — cost?: Collegium Pharmaceutical, Inc. (COLL) reported symproic and other — cost of $70M in Q4 2025.
What does symproic and other — cost mean?: Reflects the total direct costs associated with producing, distributing, and supporting the Symproic product line. Monitoring this metric helps assess the direct profitability and cost-efficiency of this specific business segment.